Navigation Links
ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
Date:9/26/2007

implications, providing the first demonstration that CXCR7 -- which was discovered as well as characterized by ChemoCentryx using our proprietary EnabaLink Drug Discovery engine -- is fundamental to cancer growth and progression and therefore, an important new cancer target," said Thomas J. Schall, Ph.D., ChemoCentryx's President and Chief Executive Officer.

Evidence of a Causal Connection between CXCR7 and Tumor Growth and Progression

In a series of carefully controlled experiments, a causal connection was identified between the presence and expression of the CXCR7 gene and tumor progression in breast and lung cancer models. In these experiments, ChemoCentryx scientists were able to clearly demonstrate the effect in vivo of up- and down-regulation of CXCR7, and how that controlled tumor growth. Isolating the CXCR7 receptor from potential interference by other chemokine receptors (such as the related receptor known as CXCR4), researchers demonstrated that CXCR7 cells formed significantly larger tumors in breast and lung cancer models. These findings extend research previously reported in the September 4, 2006 edition of The Journal of Experimental Medicine, showing that the introduction of CXCR7 into cell lines resulted in the avoidance of apoptosis, or programmed cell death, a hallmark of the uncontrolled cell proliferation associated with cancer. Further, in knockout experiments in which the CXCR7 gene was down-regulated, tumor growth was significantly impaired, thus showing that CXCR7 was required for the ability of tumors to grow well in vivo. CXCR7 expression was also observed to enhance the ability of breast cancer cells to seed and proliferate to lung tissue (metastasize) in another cancer model.

These findings appear to be clinically relevant for human cancer. The study also showed a comprehensive evaluation of over a hundred primary human breast tumor and lung tumor tissue samples removed by surgery where the presence of CXCR7 was assesse
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
2. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
3. Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
4. pFB-ERV: Retroviral Delivery of the Ecdysone Receptor Proteins
5. Gene-Specific Primers for NMDA Receptor Subunits
6. TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins
7. Quantification of the Purinergic Receptor P2X3 using ICAT and Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer
8. Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A
9. Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system
10. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
11. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Array BioPharma Inc. (Nasdaq: ... ) today announced that they entered into an ... small-molecule glucokinase activator program, including ARRY-403, currently being ... patients with Type 2 diabetes. ,, ... receive an upfront payment of $60 million and ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... Resources, one of the world,s leading research and ... that, owing to the launches of several new ... more than sevenfold from $790 million in 2008 ... States, France, Germany, Italy, Spain, the United Kingdom ... Atrial Fibrillation finds that a strong ...
(Date:12/11/2009)... 11 Dendreon Corporation (Nasdaq: DNDN ... previously announced public offering have exercised in full ... of common stock at the public offering price ... the option increases the size of the offering ... stock. Dendreon expects to receive net proceeds ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... Tenn., Jan. 13 Cumberland Pharmaceuticals Inc.,is pleased to ... In,this role, Mr. Lee will draw upon his 24 ... prospective launch and commercialization of,new products for the company. ... ) , "We are ...
... a privately held development-stage biopharmaceutical company located in San ... President of Corporate Development, will present a corporate overview ... CA, on January 14, 2009 at 2:15pm. NexBio,s ... the quality of life by creating and commercializing novel, ...
... YORK, Jan. 13 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, ... or "the Company"), a leading marketer,distributor and ... today announced that the PRC government, led ... China, the Ministry of Finance and the ...
Other Biology Technology:NexBio to Present at 2009 Biotech Showcase 2NexBio to Present at 2009 Biotech Showcase 3PRC Government Grants High-Tech Status to AOBO Subsidiaries 2PRC Government Grants High-Tech Status to AOBO Subsidiaries 3
(Date:12/14/2009)... ON, December 10, 2009If you are spending the holidays ... wondering whether you would be better off with another ... , A research team from McMaster University and ... among cichlids, a species that lives in groups, members ... The results appear in the current issue of ...
(Date:12/14/2009)... of the United Nations Framework Convention on Climate ... Agency hosted the ,Bend the Trend, event on ... platform and premiere the screening of the new ... of Europe, a joint project of the European ... and ESA, is a series of short films ...
(Date:12/13/2009)... enzymes that may help to engineer plants that take ... efficiently. The finding could help to engineer crops that ... in the carbon dioxide they need for photosynthesis through ... for each molecule of the gas gained, they lose ... pores can tighten to save water when CO 2 ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3National Institutes of Health Secures Armory with Patent Pending Technology 10647 1Simple Steps Get Walkers Moving 60853 1New finding suggests prostate biopsy is not always necessary 60850 1New finding suggests prostate biopsy is not always necessary 60850 2New finding suggests prostate biopsy is not always necessary 60850 3
... Barbara, Calif.) - It took a decade of painstaking study, ... of more than 200,000 fossil records, but John Alroy thinks ... of marine fossils and extinction rates. , Alroy, a researcher ... at UC Santa Barbara, is the principal author of a ...
... Fire & EMS Management Software Provider to Offer ... an award-winning,fingerprint biometrics research and development firm, announced ... ZOLL Data Systems(R), an,industry leader in the development ... fingerprint software and hardware to ZOLL Data,Systems, customers., ...
... makes bees hot, biologists at UC San Diego have ... meat, a separate experiment has shown. , In both ... home, allowing them to quickly exploit a valuable resource ... published this month in two scientific journals. , Because ...
Other Biology News:UCSB researcher leads worldwide study on marine fossil diversity 2M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software 2Wasps and bumble bees heat up, fly faster with protein-rich food 2Wasps and bumble bees heat up, fly faster with protein-rich food 3
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Rabbit polyclonal to Parathyroid Hormone ... all tested applications). ... to extracellular amino acids 99-116 of ... Entrez Gene ID: ...
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
... DNA-topoisomersae II inhibitor (IC50 = 59.2 M). ... 29 H 32 O 13 MolWeight: ... RT CAS: ... Soluble to 100 mM in DMSO ...
Biology Products: